ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Harvard Spin-Off SciFluor Is Launched

by Lisa M. Jarvis
May 23, 2011 | APPEARED IN VOLUME 89, ISSUE 21

SciFluor Life Sciences, a biotech firm focused on improving the pharmacokinetic properties of drugs, has launched with $5 million in first-round funding from Allied Minds. SciFluor is based on fluorination technology developed in the lab of Harvard University chemist Tobias Ritter, who is also the company’s chief technical officer. Ritter and colleagues have developed a way of introducing fluorine into a molecule without having to rework a synthetic pathway. SciFluor says fluorination can improve a compound’s metabolic stability, potency, binding affinity, and ability to cross the blood-brain barrier.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment